Our observation and previously published study [22] confirms the expression of p16 protein is absent or low in renal cell cancer samples, suggesting that loss of the p16 gene may be key event involved in renal cell cancer. The gene discussed is CDKN2A; the disease is renal cell adenocarcinoma.